S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SESN

Sesen Bio (SESN)

Sesen Bio Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SESN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
08/10/2023	6:30AM	PR Newswire (US)	Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:SESN	Sesen Bio Inc
03/06/2023	11:41AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
03/06/2023	11:35AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SESN	Sesen Bio Inc
03/03/2023	10:07AM	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:SESN	Sesen Bio Inc
03/03/2023	10:06AM	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:SESN	Sesen Bio Inc
03/02/2023	11:07AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SESN	Sesen Bio Inc
03/02/2023	10:32AM	Business Wire	Sesen Bio Stockholders Approve Merger with Carisma Therapeutics	NASDAQ:SESN	Sesen Bio Inc
02/28/2023	7:08AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/28/2023	7:03AM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SESN	Sesen Bio Inc
02/28/2023	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SESN	Sesen Bio Inc
02/28/2023	7:00AM	Business Wire	Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results	NASDAQ:SESN	Sesen Bio Inc
02/27/2023	3:33PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/27/2023	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SESN	Sesen Bio Inc
02/21/2023	8:05AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/21/2023	8:00AM	Business Wire	Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma	NASDAQ:SESN	Sesen Bio Inc
02/17/2023	7:18AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/17/2023	7:08AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/17/2023	7:04AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/17/2023	7:02AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/16/2023	4:06PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:SESN	Sesen Bio Inc
02/16/2023	3:46PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/16/2023	3:42PM	Business Wire	Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting	NASDAQ:SESN	Sesen Bio Inc
02/16/2023	7:02AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/16/2023	7:00AM	Business Wire	Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger	NASDAQ:SESN	Sesen Bio Inc
02/15/2023	3:55PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SESN	Sesen Bio Inc
02/15/2023	7:02AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/15/2023	7:00AM	Business Wire	BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics	NASDAQ:SESN	Sesen Bio Inc
02/14/2023	3:40PM	Edgar (US Regulatory)	Registration Pursuant to Securities Act Rule 462(b) of up to an Additional 20% of Securities for an Offering That Was Registered on a Form S-4 (s-4mef)	NASDAQ:SESN	Sesen Bio Inc
02/14/2023	8:08AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:SESN	Sesen Bio Inc
02/14/2023	7:00AM	Business Wire	Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger	NASDAQ:SESN	Sesen Bio Inc

Showing the most relevant articles for your search:NASDAQ:SESN

1 2 3 4 5 6 7 8 9 10 Next >>

Enzolytics (PK)

Ubiquitech Software (PK)

Canopus Biopharma (PK)

Voip Pal Com (QB)

Revance Therapeutics

Music Licensing (PK)

Branded Legacy (PK)

FuelCell Energy

Lightwave Logic

GNCC Capital (CE)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions